N8 Medical -Differentiated Dermal Filler
FromN8 Medical, LLC
N8 Medical is pursuing a novel, enhanced dermal filler product with ceragenins incorporated, designed to address key concerns in the dermal filler market.
Most popular related searches
dermal filler
hyaluronic acid
inflammation associated
inflammation reduction
hyaluronic acid filler
dermal injection
injectable dermal filler
infection reducing
infection risk
inflammation infection
- Hyaluronic acid (HA) dermal fillers represent a significant and growing global market opportunity (≈$2B in 2018) that is a private pay market with relatively undifferentiated products
- Many patients experience inflammation that delays healing and recovery, and associated pain
- Biofilm growth on HA dermal fillers is an emerging concern among clinicians
- N8 Medical’s enhanced ceragenin-infused dermal filler reduced inflammation associated with dermal filler injections in pilot study, with no safety issues observed
- N8 Medical’s enhanced ceragenin-infused dermal filler is designed to:*
- Reduce inflammation
- Enhance appearance
- Reduce infection and biofilm risk